NasdaqCM - Delayed Quote USD
CERo Therapeutics Holdings, Inc. (CEROW)
0.0099
0.0000
(0.00%)
At close: June 10 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Christopher B. Ehrlich M.B.A. | CEO & Chair | 1.08M | -- | 1970 |
| Mr. Andrew Albert Kucharchuk M.B.A. | Chief Financial Officer | 252k | -- | 1981 |
| Dr. Kristen Pierce Ph.D. | Chief Development Officer | 360k | -- | 1971 |
| Dr. Lawrence Corey M.D. | Co-founder & Head of Scientific Advisory Board | -- | -- | 1947 |
CERo Therapeutics Holdings, Inc.
201 Haskins Way
Suite 230
South San Francisco, CA 94080
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 8
Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Corporate Governance
CERo Therapeutics Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
COEPW Coeptis Therapeutics Holdings, Inc.
0.0241
-1.63%
ENSCW Leisure Acquisition Corp.
0.0241
+20.50%
DRMAW Dermata Therapeutics, Inc.
0.0175
+1.74%
APLMW Apollomics, Inc.
0.0178
+14.10%
OSRHW OSR Holdings, Inc.
0.0526
-2.59%
PTIXW Protagenic Therapeutics, Inc.
0.0500
-4.21%
CDTTW Conduit Pharmaceuticals Inc.
0.0091
-9.00%
ABPWW Abpro Holdings Inc
0.0192
-0.52%
NLSPW NLS Pharmaceutics AG
0.0225
+18.42%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0060
0.00%